deCODE genetics publishes multiomics study of nonalcoholic fatty liver disease
Scientists at deCODE genetics in Iceland have discovered rare, protective loss-of-function variants that point to potential drug targets for nonalcoholic fatty liver disease (NAFLD). REYKJAVIK, Iceland, Oct. 24, 2022 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, publish today a large genome-wide association study on nonalcoholic fatty liver disease (NAFLD) in Nature Genetics. Gardar Sveinbjornsson leading...
ReviR Therapeutics Expands Research Team by Appointing Dr. Sridhar Narayan as Head of Medicinal Chemistry
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2022 /PRNewswire/ -- ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule drugs, recently announced the appointment of Dr. Sridhar Narayan as Vice President responsible for the global Medicinal Chemistry team. "I am delighted to welcome Dr. Narayan to the team. He is a seasoned 'drug-hunter' who brings deep operational expertise...
Waterdrop Explores Offline Insurance Brokerage
BEIJING, Oct. 24, 2022 /PRNewswire/ -- Since 2022, Waterdrop has stepped up offline brokerage, and offered offline brokers with multiple development directions including organization development mode, independent agent mode, and community outlet mode, in an effort to build an elite service team. It has also launched WFind (Waterdrop Family Insurance Needs Diagnosis) to drive professional operation by brokers....
Gracell Biotechnologies to Participate in Two Upcoming Investor Conferences
SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Oct. 24, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one...
Transcenta to Participate in Four Upcoming Conferences
SUZHOU, China, Oct. 24, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical-stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development, and manufacturing of antibody-based therapeutics, announces that the management team will participate in four upcoming investor conferences in October and November 2022 as follows: 1) 2022 Listed Companies Roadshow Conference* Season 3 (Pharmaceutical and Biological Industry)...
Invivoscribe files sPMA with the FDA for use of the LeukoStrat CDx FLT3 Mutation Assay to Select Patients with Newly Diagnosed FLT3-ITD Positive AML
SAN DIEGO, Oct. 24, 2022 /PRNewswire/ -- Invivoscribe is pleased to announce that they have filed a supplemental Pre-Market Approval (sPMA) submission with the U.S. Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH) for the use of the LeukoStrat® CDx FLT3 Mutation Assay as the companion diagnostic for Daiichi Sankyo's...
India’s most advanced and largest IVF clinic group, Indira IVF, will offer all patients Artificial Intelligence technology to improve pregnancy outcomes
SAN FRANCISCO, Oct. 24, 2022 /PRNewswire/ -- The largest and most advanced IVF clinic group in India, Indira IVF, will be rolling out the latest in Artificial Intelligence technology across their 100+ clinics in India in November 2022. This AI technology, called Life Whisperer, has been tested in a number of international...
Polaris Dawn Selects 38 Science and Research Experiments to Advance Human Health and Space Exploration
LOS ANGELES, Oct. 24, 2022 /PRNewswire/ -- Polaris Dawn, the first of the Polaris Program's three human spaceflight missions, announced today the extensive suite of science and research experiments the crew and SpaceX will conduct throughout the mission. The selected projects are designed to advance both human health on Earth and on...
Large-scale clinical study shows CU Medicine (SIM01) microbiome formula reduces risk of infections including COVID-19
HONG KONG, Oct. 24, 2022 /PRNewswire/ -- A randomised, double-blind controlled study conducted by The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) showed that SIM01, a CUHK-developed microbiome formula, successfully reduced adverse events in high-risk individuals such as elderly subjects and diabetics following COVID-19 vaccines. The research team also...
Ping An Health acquires Ping An Smart Healthcare
Harnessing synergies to empower Ping An's managed care business model HONG KONG and SHANGHAI, Oct. 24, 2022 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or "Ping An Health"; Stock Code: 1833.HK), announced the acquisition of Ping An Smart Healthcare, a business segment of Ping An Smart City. Going forward, while the Company continues...
